Cargando…

HNRNPM Regulates HCC Tumorigenesis and Cancer Stemness: Identification of a Novel Therapeutic Target?

Detalles Bibliográficos
Autor principal:	Kennedy, Lindsey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043298/ https://www.ncbi.nlm.nih.gov/pubmed/35245497 http://dx.doi.org/10.1016/j.jcmgh.2022.02.012

Ejemplares similares

Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma
por: Zhu, Gui-Qi, et al.
Publicado: (2022)

The bovine leukemia virus-derived long non-coding RNA AS1-S binds to bovine hnRNPM and alters the interaction between hnRNPM and host mRNAs
por: Andoh, Kiyohiko, et al.
Publicado: (2023)

CDR1as regulated by hnRNPM maintains stemness of periodontal ligament stem cells via miR‐7/KLF4
por: Gu, Xiuge, et al.
Publicado: (2021)

Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
por: Harvey, Samuel E., et al.
Publicado: (2018)

hnRNPM induces translation switch under hypoxia to promote colon cancer development
por: Chen, Tsung-Ming, et al.
Publicado: (2019)

HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness
por: Ho, Jessica SY, et al.
Publicado: (2021)

Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
por: Xu, Yilin, et al.
Publicado: (2014)

Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017)

RNA-recognition motif in Matrin-3 mediates neurodegeneration through interaction with hnRNPM
por: Ramesh, Nandini, et al.
Publicado: (2020)

Novel Molecular Mechanisms Underlying Tumorigenesis and Innovative Therapeutic Approaches for Cancer-Fighting
por: Pecoraro, Annalisa, et al.
Publicado: (2023)

HCC, diet and metabolic factors: Diet and HCC
por: Montella, Maurizio, et al.
Publicado: (2011)

Promoter-Dependent Translation Controlled by p54(nrb) and hnRNPM during Myoblast Differentiation
por: Ainaoui, Nadera, et al.
Publicado: (2015)

Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
por: Meng, Hongwu, et al.
Publicado: (2022)

Calcium Regulates HCC Proliferation as well as EGFR Recycling/Degradation and Could Be a New Therapeutic Target in HCC
por: Modica, Teresa Maria Elisa, et al.
Publicado: (2019)

Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets
por: Dräger, Oliver, et al.
Publicado: (2021)

Downregulation of HNRNPM inhibits cell proliferation and migration of hepatocellular carcinoma through MAPK/AKT signaling pathway
por: Qiao, Lu, et al.
Publicado: (2022)

The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy
por: Ren, Yin-Xiang, et al.
Publicado: (2022)

Novel Therapeutic Targets in Cancers
por: Levantini, Elena
Publicado: (2023)

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Intratumor heterogeneity in HCC
por: Friemel, Juliane, et al.
Publicado: (2015)

C. elegans SUP-46, an HNRNPM family RNA-binding protein that prevents paternally-mediated epigenetic sterility
por: Johnston, Wendy L., et al.
Publicado: (2017)

Cancer Cell-Derived Exosomes Promote HCC Tumorigenesis Through Hedgehog Pathway
por: Li, Li, et al.
Publicado: (2021)

AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019)

MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1
por: Yin, Liang-Chun, et al.
Publicado: (2020)

circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway
por: Shou, Yi, et al.
Publicado: (2023)

Molecular network of HCC aggressiveness
por: Kim, Sang Geon, et al.
Publicado: (2015)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
por: Słomka, Artur, et al.
Publicado: (2020)

Roles of circRNAs in the Tumorigenesis and Metastasis of HCC: A Mini Review
por: Liu, Yichen, et al.
Publicado: (2022)

Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy
por: Wu, Yafei, et al.
Publicado: (2020)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
por: Bei, Roberto, et al.
Publicado: (2023)

Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis
por: Haxho, Fiona, et al.
Publicado: (2016)

Novel paradigms of macrophage biology and function: identification of disease biomarkers and therapeutic targets
por: Wang, Diane Catherine, et al.
Publicado: (2022)

Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells
por: Shrestha, Ritu, et al.
Publicado: (2021)

Incapacitated Capicua in Sorafenib-Resistant HCC
por: Yin, Dingzi, et al.
Publicado: (2020)

Novel Cellular Functions of ATR for Therapeutic Targeting: Embryogenesis to Tumorigenesis
por: Biswas, Himadri, et al.
Publicado: (2023)

Identification and Targeting of Stem Cell-Activated Pathways in Cancer Therapy
por: Budillon, Alfredo, et al.
Publicado: (2019)

Novel Oncology Therapeutics: Targeted Drug Delivery for Cancer
por: Tzakos, Andreas G., et al.
Publicado: (2013)

Semaphorin 4A as novel regulator and promising therapeutic target in rheumatoid arthritis
por: Chapoval, Svetlana P.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_doce6kc8mbrqarj6e0nnc8037o